MedTech News
.................... by Andrew Celentano
Exposure to bright evening light linked to higher risk of age-related eye disease
Researchers found that exposure to bright artificial light in the evening, especially between 8 p.m. and 11:30 p.m., may significantly increase the risk of developing serious eye diseases later in life.
Faster Biological Aging May Help Explain Why More Younger Adults Are Getting Cancer
Younger generations are now aging faster than their parents and grandparents, and this aging gap could explain the rise in early-onset cancers.
FDA Approves Gilead’s Trodelvy, Alone and With Merck’s Keytruda, in First-Line Metastatic TNBC
Decision delivers the first ADC-based regimens for previously untreated triple-negative breast cancer across PD-L1 status, a PD-L1-positive Keytruda combination plus a monotherapy option for immunotherapy-ineligible patients.
A Noninvasive Way to Monitor Babies’ Health
A tiny silk sticker that visibly shows vital health signals, read by an AI system, could change how we care for the tiniest patients
Cyclana Bio granted Health Research Authority approval
Cyclana Bio, a biotechnology company pioneering tissue-level approaches to women’s health, has announced it has received Health Research Authority (HRA) and Research Ethics Committee (REC) approval for its 500-patient clinical observational study, PEMP (Predicting Endometriosis Mechanisms and Populations).
Spotlight Medical lands IVDR CE Mark for AI Breast Cancer Test
Spotlight Medical, a Paris-based oncology diagnostics company, has announced that myStage Dx has received CE marking under the European Union In Vitro Diagnostic Medical Devices Regulation (IVDR, Regulation (EU) 2017/746).
Gut fungi may hold the key to treating asthma worldwide
One paper by Dr. Stuart Turvey and colleagues at BC Children’s Hospital Research Institute (BCCHR) and another paper by Dr. Marie-Claire Arrieta and colleagues from the Snyder Institute for Chronic Diseases and the Alberta Children’s Hospital Research Institute reveal key to treating asthma.
New blood test detects more high-risk prostate cancer cases
In a study from Karolinska Institutet, the Stockholm3 blood test detected more clinically significant cancer cases than the PSA test, without subjecting more men to unnecessary testing.